Navigation Links
Bend Research Offers Broad Access to Drug-Delivery Solutions
Date:10/20/2008

BEND, Ore., Oct. 20 /PRNewswire/ -- Bend Research Inc. announced today that it will independently offer unique drug-delivery expertise and technologies to outside firms in the pharmaceutical and biotechnology industries.

Bend Research will continue its 23-year collaboration with Pfizer but will also be free to work with outside firms using proprietary technologies developed jointly by the two firms.

These technologies include the spray-dried dispersion (SDD) technology (which increases the oral bioavailability of low-solubility compounds), controlled-release, multiparticulate, and pulmonary delivery platforms.

Bend Research CEO Rod Ray commented: "Our work with Pfizer has helped us tremendously to grow and develop our capabilities over the past two decades. In return, we have helped Pfizer advance a significant number of their compounds. Today, we're pleased to have the opportunity to collaborate with additional clients to enable the delivery of new medicines."

Kelvin Cooper, Senior Vice President of Worldwide Pharmaceutical Sciences for Pfizer Global Research and Development, agreed: "Our collaboration with Bend Research has proved to be valuable and we look forward to continued work with Bend Research. Through this agreement, we hope the technologies we've developed together will help speed the introduction of new medicines to patients throughout the world."

Under terms of the agreement with Pfizer, Bend Research will have the ability to employ expertise and processes developed with Pfizer to benefit other drug developers. These include optimized drug discovery, dosage form development, engineering capabilities, and manufacture of supplies for clinical trials under Good Manufacturing Practice (GMP) conditions.

Bend Research will continue to work exclusively with Pfizer on certain specific technology platforms. This commitment reaffirms the strong relationship between the two companies while providing enabling technologies for improved world health

About Bend Research Inc.

Bend Research Inc. is an interdisciplinary technology-, science-, and engineering-driven company that discovers, advances, develops, and commercializes pharmaceutical and healthcare products through the application of technology platforms. This capability is driven by scientific and engineering excellence. The company has three facilities based in Bend, Oregon.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
2. The Wellness Community Announces National Cancer Survivorship Research & Training Institute in Philadelphia
3. Research May Help Predict Preeclampsia
4. Georgetown University Med Center reproductive health researchers tackle public health concerns
5. Monash wins $32m for health and medical research
6. New research shows that the smell of smoke does not trigger relapse in quitters
7. Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
8. American Cancer Society awards research grants to 116 investigators at 75 institutions nationwide
9. Steroids aid recovery from pneumonia, UT Southwestern researchers say
10. Carnegie Mellon International Autism Symposium to Feature Groundbreaking Research, Oct. 17-18
11. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... From May ... Chicago, IL, offering EarQ members the unique opportunity to learn more about Signia’s technology ... independent practice growth. , “It is our priority to see practices succeed in this ...
(Date:5/6/2016)... San Diego, CA (PRWEB) , ... May 06, 2016 , ... ... of Companies, has been family-owned and operated for over 35 years. Maintaining core values ... community has driven their success and made them a leading name in San Diego ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... and David Konur, CEO of Cardiovascular Institute of the South announced today that ... performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... overall select performance in the industry’s gold standard KLAS Performance Report, ... Epic Consulting report assessed organizations that specialize in consulting services for electronic health ...
(Date:5/5/2016)... ... May 05, 2016 , ... Florida Hospital Pepin ... atrial fibrillation (A-Fib) an alternative to long-term warfarin medication with the newly approved ... April of 2015, Florida Hospital Pepin Heart Institute doctors successfully implanted the Watchman ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016  Compass Diversified Holdings (NYSE: CODI ... of leading middle market businesses, announced today its consolidated ... 2016. First Quarter 2016 Highlights , ... or "Cash Flow") of $13.6 million for the first ... $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... ZIONA, Israel , May 4, 2016 ... BVXV) announced today that BiondVax,s CEO, Dr. Ron Babecoff ... in New York City . ... 10:30am at Pioneers 2016, a conference presented by Joseph ... Palace Hotel. The BiondVax presentation that Dr. Babecoff ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
Breaking Medicine Technology: